Provided by Tiger Trade Technology Pte. Ltd.

Insmed

120.00
-3.9800-3.21%
Post-market: 120.000.00000.00%18:26 EDT
Volume:3.44M
Turnover:416.22M
Market Cap:26.21B
PE:-29.35
High:124.11
Open:123.89
Low:119.32
Close:123.98
52wk High:212.75
52wk Low:90.39
Shares:218.38M
Float Shares:216.82M
Volume Ratio:1.78
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0882
EPS(LYR):-6.4200
ROE:-87.22%
ROA:-22.17%
PB:34.60
PE(LYR):-18.69

Loading ...

BRIEF-Insmed Q1 Net Income USD -163.6 Million

Reuters
·
May 07

Insmed Inc - Reiterates 2026 Arikayce Revenue Guidance of $450 Mln-$470 Mln

THOMSON REUTERS
·
May 07

Insmed Inc - Reiterates 2026 Brinsupri Revenue Guidance of at Least $1 Bln

THOMSON REUTERS
·
May 07

Insmed Inc - Cash, Cash Equivalents, and Marketable Securities $1.2 Bln as of March 31, 2026

THOMSON REUTERS
·
May 07

Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 07

Insmed Chair, CEO William Lewis disposes 10,699 shares for $1.46 million

Reuters
·
May 07

Rising Institutional Interest and Brinsupri Focus Might Change The Case For Investing In Insmed (INSM)

Simply Wall St.
·
May 05

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-05-04

Reuters
·
May 04

Insmed presents late-breaking Phase 3b ENCORE ARIKAYCE data at ATS 2026

Reuters
·
May 04

Insmed price target raised to $214 from $212 at BofA

TIPRANKS
·
May 04

Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Hims & Hers Health (HIMS) and Insmed (INSM)

TIPRANKS
·
May 04

Earning Preview: Insmed Q1 revenue is expected to increase by 227.48%, and institutional views are bullish

Earnings Agent
·
May 01

Analysts’ Opinions Are Mixed on These Healthcare Stocks: United Therapeutics (UTHR), Insmed (INSM) and MannKind (MNKD)

TIPRANKS
·
Apr 28

Insmed (INSM) Initiated with a Buy at Evercore ISI

TIPRANKS
·
Apr 27

If You Believe In Transformative AI Healthcare Then These Three Stocks Could Define Your Next Cycle

Simply Wall St.
·
Apr 27

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-04-24

Reuters
·
Apr 25

Insmed’s TPIP Extension Study Completion: What Long-Term PH-ILD Data Could Mean for INSM Investors

TIPRANKS
·
Apr 24

Insmed schedules first-quarter financial results conference call

Reuters
·
Apr 23

Insmed Chair, CEO William Lewis disposes of shares worth $1,532,026.22

Reuters
·
Apr 18

Insmed Price Target Maintained With a $212.00/Share by Roth Capital

Dow Jones
·
Apr 18